Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 125, 2019 - Issue 3
226
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Reversal of high fat diet-induced obesity through modulating lipid metabolic enzymes and inflammatory markers expressions in rats

, , , , , , , & show all
Pages 228-234 | Received 12 Jan 2018, Accepted 08 Mar 2018, Published online: 19 Mar 2018

References

  • Bays, H., Blonde, L., and Rosenson, R., 2009. Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients? Expert review of cardiovascular therapy, 4 (6), 871–895.
  • Bhandari, U., et al., 2011. The effect of high-fat diet induced obesity on cardiovascular toxicity in wistar albino rats. Human & experimental toxicology, 30, 1313–1321.
  • Brahmanaidu, P., et al., 2016a. Effects of S-allylcysteine on biomarkers of polyol pathway in experimental type II diabetes in rats. Canadian journal of diabetes, 40, 442–448.
  • Brahmanaidu, P., et al., 2016b. Ameliorative potential of gingerol: promising modulation of inflammatory factors and lipid marker enzymes expressions in HFD induced obesity in rats. Molecular and cellular endocrinology, 419, 139–147.
  • Brahmanaidu, P., et al., 2017. Reversal of endothelial dysfunction in aorta of streptozotocinnicotinamide-induced type-2 diabetic rats by S-Allylcysteine. Molecular and cellular biochemistry, 432 (1–2), 25–32.
  • Browning, J.D., Szczepaniak, L.S., and Dobbins, R., 2004. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology, 40, 1387–1395.
  • De Melo, C.L., Queiroz, M.G.R., and Arruda Filho, A.C.V., 2009. Betulinic acid, a natural pentacyclic triterpenoid, prevents abdominal fat accumulation in mice fed a high-fat diet. Journal of agricultural and food chemistry, 57, 8776–8781.
  • Despres, J.P., 2012. Body fat distribution and risk of cardiovascular disease: an update. Circulation, 126, 1301–1313.
  • Ferre, P. and Foufelle, F., 2010. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes, obesity and metabolism, 12, 83–92.
  • Fried, M., et al., 2008. Interdisciplinary European guidelines on surgery for severe obesity. Rozhledy V chirurgii, 87, 468–476.
  • Garjani, A., et al., 2009. The effect of total extract of Securigera securidaca L. seeds on serum lipid profiles, antioxidant status, and vascular function in hypercholesterolemic rats. Journal of ethnopharmacology, 126, 525–532.
  • Glass, C.K. and Olefsky, J.M., 2012. Inflammation and lipid signalling in the etiology of insulin resistance. Cell metabolism, 15, 635–645.
  • Hardie, D.G., 2008. AMPK: a key regulator of energy balance in the single cell and the whole organism. International journal of obesity, 32, 7–12.
  • Istvan, E.S., 2002. Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl co enzyme A reductase. American heart journal, 144, 27–32.
  • Jin, D., Xua, Y., and Mei, X., 2013. Antiobesity and lipid lowering effects of the aflavins on high-fat diet induced obese rats. Journal of functional foods, 5, 1142–1150.
  • Kalaivani, A., et al., 2017. Anti obese potential of Cucurbita maxima seeds oil: effect on lipid profile and histoarchitecture in high fat diet induced obese rats. Natural product research. doi: 10.1080/14786419.2017.1389939
  • Kim, Y. and Park, T., 2008. Genes are differentially expressed in the epididymal fat of rats rendered obese by a high-fat diet. Nutrition research, 28, 414–422.
  • Lami, A.A., Barakat, R., and Hamed, M., 2011. The antiatherogenic, renal protective and immunomodulatory effects of purslane, pumpkin and flax seeds on hypercholesterolemic rats. North American journal of medical sciences, 3 (9), 351–357.
  • Magana, M.M. and Osborne, T.F., 1996. Two tandem binding sites for sterol regulatory element binding proteins are required for sterol regulation of fatty-acid synthase promoter. The journal of biological chemistry, 271, 32689–32694.
  • Munday, M.R., 2002. Regulation of mammalian acetyl-CoA carboxylase. Biochemical society transactions, 30, 1059–1064.
  • Nawrocki, A.R. and Scherer, P.E., 2005. Keynote review: the adipocyte as a drug discovery target. Drug discovery today, 10, 1219–1230.
  • Nkosi, C.Z., Opoku, A.R., and Terblanche, S.E., 2006. Antioxidative effects of pumpkin seed (Cucurbita pepo) protein isolate in CCl4-induced liver injury in low-protein fed rats. Phytotherapy research, 20 (11), 935–940.
  • Oben, J., et al., 2006. The use of a Cissus quadrangularis formulation in the management of weight loss and metabolic syndrome. Lipids in health and disease, 5, 24.
  • Ono, Y., et al., 2006. Anti-obesity effect of Nelumbo nucifera leaves extract in mice and rats. Journal of ethnopharmacology, 106, 238–244.
  • Park, Y., et al., 2004. Structure–activity relationship of conjugated linoleic acid and its cognates in inhibiting heparin-releasable lipoprotein lipase and glycerol release from fully differentiated 3T3-L1 adipocytes. The journal of nutritional biochemistry, 15, 561–569.
  • Rameshreddy, P., et al., 2017. Obesity-alleviating potential of asiatic acid and its effects on ACC1, UCP2, and CPT1 mRNA expression in high fat diet-induced obese Sprague–Dawley rats. Molecular and cellular biochemistry. doi: 10.1007/s11010-017-3199-2
  • Saravanan, G., et al., 2014. Anti-obesity action of gingerol: effect on lipid profile, insulin, leptin, amylase and lipase in male obese rats induced by a high-fat diet. Journal of the science of food and agriculture, 94, 2972–2977.
  • Sathibabu Uddandrao, V.V., et al., 2017. Beneficial role of some natural products to attenuate the diabetic cardiomyopathy through Nrf2 pathway in cell culture and animal models. Cardiovascular toxicology. doi: 10.1007/s12012-017-9430-2
  • Shen, C.L., et al., 2010. Green tea polyphenols mitigate bone loss of female rats in a chronic inflammation induced bone loss model. Journal of nutritional biochemistry, 10, 968–974.
  • Solinas, G. and Karin, M., 2010. Molecular links between obesity and metabolic dysfunction. The FASEB journal, 24, 2596–2611.
  • Tundis, R., Loizzo, M.R., and Menichini, F., 2010. Natural products as alpha-amylase and alpha-glucosidase inhibitors and their hypoglycaemic potential in the treatment of diabetes: an update. Mini-reviews in medicinal chemistry, 10, 315–331.
  • Uddandrao Sathibabu, V.V., Brahmanaidu, P., and Saravanan, G., 2017. Therapeutical perspectives of S-allylcysteine: effect on diabetes and other disorders in animal models. Cardiovascular & hematological agents in medicinal chemistry, 15, 71–77.
  • Van Herpen, N.A. and Schrauwen-Hinderling, V.B., 2008. Lipid accumulation in nonadipose tissue and lipotoxicity. Physiology & behavior, 94, 231–241.
  • Xie, W., Wang, W., and Su, H., 2007. Hypolipidemic mechanisms of Ananas comosus L. leaves in mice: different from fibrates but similar to statins. Journal of pharmacological sciences, 10, 267–274.
  • Zhu, L.-H., Wang, A., and Luo, P., 2014. Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor a in mice. Journal of hepatology, 60, 1046–1054.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.